NeuroPace to Participate in 2026 Cantor Global Healthcare Conference

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in the upcoming 2026 Cantor Global Healthcare Conference.

NeuroPace management will participate in a fireside chat discussion on Wednesday, September 9 at 10:55am EDT, and host one-on-one meetings with investors during the conference. The fireside chat will be accessible via a live webcast here and a replay will be available on the Events section of NeuroPace’s Investor website at https://investors.neuropace.com/news-and-events/events.

About NeuroPace, Inc.

Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260901798004/en/

Investor Contact:
Scott Schaper
Head of Investor Relations
[email protected]
[email protected]

Source: NeuroPace, Inc.

You May Also Be Interested In

• ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients
• KBRA Assigns A- with Stable Outlook to Monterey Peninsula Airport District Airport Revenue Bonds and TIFIA Loan
• Greenberg Traurig's Allison Ng Named NAPABA 'Best Under 40'